Market Update: Maravai LifeSciences Holdings Inc (MRVI) Sees Positive Movement, Closing at 4.55

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) closed at $4.55 up 2.94% from its previous closing price of $4.42. In other words, the price has increased by $2.94 from its previous closing price. On the day, 3.32 million shares were traded. MRVI stock price reached its highest trading level at $4.65 during the session, while it also had its lowest trading level at $4.275.

Ratios:

For a deeper understanding of Maravai LifeSciences Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.94 and its Current Ratio is at 10.74. In the meantime, Its Debt-to-Equity ratio is 1.63 whereas as Long-Term Debt/Eq ratio is at 1.59.

On August 28, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $10.Wells Fargo initiated its Overweight rating on August 28, 2024, with a $10 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 12 ’24 when DeFord John A bought 17,500 shares for $5.75 per share. The transaction valued at 100,625 led to the insider holds 70,046 shares of the business.

HULL CARL bought 175,000 shares of MRVI for $987,000 on Nov 11 ’24. The insider now owns 175,000 shares after completing the transaction at $5.64 per share. On May 28 ’24, another insider, GTCR INVESTMENT XI LLC, who serves as the Director of the company, sold 9,940,974 shares for $9.81 each. As a result, the insider received 97,570,660 and left with 20,150,005 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRVI now has a Market Capitalization of 1116174208 and an Enterprise Value of 948560960. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.53 while its Price-to-Book (P/B) ratio in mrq is 1.87. Its current Enterprise Value per Revenue stands at 3.425 whereas that against EBITDA is 915.599.

Stock Price History:

Over the past 52 weeks, MRVI has reached a high of $11.56, while it has fallen to a 52-week low of $4.39. The 50-Day Moving Average of the stock is -40.71%, while the 200-Day Moving Average is calculated to be -43.80%.

Shares Statistics:

For the past three months, MRVI has traded an average of 2.08M shares per day and 3550830 over the past ten days. A total of 132.23M shares are outstanding, with a floating share count of 117.53M. Insiders hold about 17.14% of the company’s shares, while institutions hold 87.88% stake in the company. Shares short for MRVI as of 1730332800 were 8218867 with a Short Ratio of 3.96, compared to 1727654400 on 9219389. Therefore, it implies a Short% of Shares Outstanding of 8218867 and a Short% of Float of 6.9299996.

Most Popular